Can Pharmacogenetic Variants in TPMT, MTHFR and SLCO1B1 Genes Be Used as Potential Markers of Outcome Prediction in Systemic Sclerosis Patients?

Systemic sclerosis (SSc) is a rare connective tissue disorder with highest morbidity and mortality among rheumatologic diseases. Disease progression is highly heterogeneous between patients, implying a strong need for individualization of therapy. Four pharmacogenetic variants, namely TPMT rs1800460...

Descripción completa

Detalles Bibliográficos
Autores principales: Jelovac, Marina, Kotur, Nikola, Ristivojevic, Bojan, Pavlovic, Djordje, Spasovski, Vesna, Damjanov, Nemanja, Pavlovic, Sonja, Zukic, Branka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217985/
https://www.ncbi.nlm.nih.gov/pubmed/37239884
http://dx.doi.org/10.3390/ijms24108538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217985/
https://www.ncbi.nlm.nih.gov/pubmed/37239884
http://dx.doi.org/10.3390/ijms24108538

Ejemplares similares